John H. Stroger, Jr. Hospital of Cook County, Div. of Hematology and Oncology

Chicago, Illinois 60612

0 studies enrolling now · 2 studies all time

What they study most

Chronic Idiopathic Thrombocytopenic Purpura, Idiopathic Thrombocytopenic Purpura, Purpura, Thrombocytopenic, Idiopathic

Studies at this site

• Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With ChronicITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003 — Completed
• Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) — Completed